Esperion Therapeutics, Inc. earnings per share and revenue

ESPR earnings per share for the last quarter are -0.50 USD whereas the estimation was -0.48 USD which accounts for -3.80% surprise. Företagets omsättning för samma period uppgår till 32.25 M USD trots den uppskattade siffran 28.65 M USD. Estimated earnings per share for the next quarter are 0.05 USD, and revenue is expected to reach 84.56 M USD. Also watch annual changes over time to get a bigger picture of ESPR earnings per share and revenue dynamics.